Carolina McCalmon, a physician assistant with Novant Health Neurology Department, was in the studio to talk more about ways ...
A proprietary monoclonal antibody targeting an inhibitory immune checkpoint pathway had favorable safety and tolerability in ...
Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.
1hon MSN
Research suggests eating meat might be linked to a lower risk of dementia—but there’s a big catch
Here’s what experts say.
The future just got brighter, thanks to the sunshine vitamin. Scientists in Ireland have added to a growing stack of research ...
The National Institutes of Health has renewed support for Artificial Intelligence for Alzheimer's Disease, or AI4AD. The new $12.6 million award to advance the project's next phase, AI4AD2, brings its ...
Scientists may have sniffed out a breakthrough when detecting Alzheimer’s. The degenerative disease, which affects millions ...
A UTHealth Houston physician's visit to a local public health building sparked community awareness and inspired a new ...
For writer Zelik Bocknek, what first seemed like a harmless part of getting older — small memory lapses, confusion, changes ...
Most people think of Alzheimer's disease as an illness of aging. But in fact, the brain changes that characterize it begin ...
GLP-1 receptor agonist indications continue to expand beyond glycaemic and weight control, with benefits now shown in chronic ...
Women show higher neuritic plaque burden than men in AD, influenced by race, African ancestry, and APOE ε4 status, according to a new autopsy study.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results